Ellevest, Inc. - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ellevest, Inc. ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q1 2023$1,976
-25.4%
81
-3.6%
0.00%
Q4 2022$2,649
-11.7%
84
-27.0%
0.00%
Q2 2022$3,000
+200.0%
115
+187.5%
0.00%
Q1 2022$1,0000.0%400.0%0.00%
Q4 2021$1,000400.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2021
NameSharesValueWeighting ↓
Anchor Investment Management, LLC 100$4,2400.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders